Application 021149

Type
BLA
Sponsor
EMD SERONO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OVIDRELCHORIOGONADOTROPIN ALFAINJECTABLE;INJECTION0.25MG/VIALNoNo
002OVIDRELCHORIOGONADOTROPIN ALFAINJECTABLE;SUBCUTANEOUSEQ 0.25MG /0.5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
44087-1150Ovidrelchoriogonadotropin alfaEMD Serono, Inc.BLACurrent
44087-1150Ovidrelchoriogonadotropin alfaEMD Serono, Inc.BLACurrent
44087-1150Ovidrelchoriogonadotropin alfaEMD Serono, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
62244APPL2020-03-23
41985ORIG2020-03-23
26908SUPPL2020-03-23
26907SUPPL2020-03-23
14504SUPPL2020-03-23
14503SUPPL2020-03-23
14502ORIG2020-03-23
4472SUPPL2020-03-23
4471ORIG2020-03-23